DescriptionMAP3K8/Tpl2/COT Polyclonal antibody specifically detects MAP3K8/Tpl2/COT in Human samples. It is validated for Western Blot
|PBS buffer, 2% sucrose|
|Western Blot 1.0 ug/ml|
|Cancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 18.104.22.168, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2|
|The immunogen is a synthetic peptide directed towards the N terminal region of human MAP3K8/Tpl2/COT. The peptide sequence for this immunogen was taken from within the described region.|
|Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok